Sunday, May 17, 2015 3:52:35 PM
May 8, 2015 (1:00PM)
NYU Langone Medical Center raised more than $7 million last night at its annual Violet Ball held at Cipriani on 42nd Street in New York City.
...
...
Leadership supporters of this year’s Violet Ball included the Harrises, the Tisch family, and NYU Langone Trustees Lori Fink (also chair, Perlmutter Cancer Center Advisory Board) and Laurence D. Fink (chairman and CEO, BlackRock, Inc.), Elaine and Ken Langone, and Martin and Susan Lipton.
Mr. Langone, chair of the Board of Trustees at NYU Langone, served as Gala Chair, and Dr. Grossman was the Physician Committee Chair.
nyulangone.org/press-releases/over-7-million-raised-at-nyu-langone-medical-centers-2015-violet-ball
Since BlackRock draws attention to itself, we must ask all the tough questions and anyone would naturally look down all paths... though many lead no where, some do.....
For now and just to start... take a look at this Fink/BlackRock/Perlmutter Cancer Center Advisory Board connection...
----------------
https://www.med.nyu.edu/cancer/about-us
Senior Leadership
Benjamin Neel, MD, PhD
Barbara A. Vance, PhD, CRA
Abraham Chachoua, MD
Francisco Esteva, MD
Richard Hayes, DDS, PhD
David Levy, PhD
Iman Osman, MD
Mark Philips, MD
Robert Schneider, PhD
James L. Speyer, MD
Associate Director, Strategic Planning, Network Development, and Public Affairs
Dr. Speyer is a Professor in the Laura and Isaac Perlmutter Division of Hematology and Medical Oncology.
Kevin Kirchen
Vice President of Operations, NYU Langone Medical Center
Michael J. Zeller
Senior Administrative Director, Operations, Business, and Finance
James Loos
Administrative Director, Operations, Business, and Finance
Joan Scagliola, RN
Senior Director of Nursing, Ambulatory Oncology
Board of Advisors
Lori Fink, Chairperson
Ellen Banner
Phyllis Putter Barasch
Susan Block Casdin
Norman M. Feinberg
Roberta Greenberg
Celeste Guth
James M. Kenny
Rita Kwiat
Kenneth G. Langone
Edward J. Minskoff
Laura Perlmutter
Joshua Samuelson
Stanley Shopkorn
Constance M. Silver
Debora Staley
Joseph S. Steinberg
Brian Walter
http://nyulangone.org/locations/perlmutter-cancer-center/leadership-board-of-advisors
---------------------------------------------
Next, how about Laura Perlmutter ?
Early in his career, Perlmutter met his wife Laurie J. Perlmutter at a Catskills resort and they married soon after. They divide their time between homes in West Palm Beach, Florida and New York.[5]
Perlmutter takes great pride in never having given an interview over his entire career despite being in the public eye due to his many court battles and bankruptcy fights. He has rarely been spontaneously photographed.[5]
...
..
in 1993, Perlmutter and his wife established the Laura and Isaac Perlmutter Professorship and Chair in Cell Biology at the Skirball Institute of Biomolecular Medicine (part of the New York University School of Medicine). In addition, Mrs. Perlmutter has served as a trustee on the NYU Medical Center's Board of Trustees since 1993.
http://en.wikipedia.org/wiki/Isaac_Perlmutter
-------------------------------------------
So this all started by easily seeing "no clinical trials" offered in NY for Bavituximab+Docetaxel in Sunrise Phase III and why?? ... connecting those BlackRock dots to NYU hospital networks and the resistance they naturally have against Peregrine/PS Targeting to advance and Lori/Laurence Fink... and now seeing Lori Fink is also Chair of Perlmutter Cancer Center Advisory Board.... so we shall see where this path leads.....
http://www.forbes.com/profile/isaac-perlmutter/
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
